Klonopin
(Clonazepam)ApprovedSmall molecule
Clonazepam is used to treat anxiety disorders, panic attacks, and seizures. It works by calming overactive brain activity and helping people feel more relaxed.[2] Klonopin is currently approved and in use across 12 indications[4].[1]
Klonopin is one of 288 small molecule programs targeting Neuropathic Pain. It is currently in Approved.
12
Indications
29
Total Trials
4
Active Trials
287
Competitors
2
FDA Applications
NDA/BLA/ANDA regulatory filings
Pipeline
Status by Indication[4][1]
Indication
Showing 10 of 12 indications
Competition
Competitive Landscape
583 competitors in Schizophrenia
#DrugCompanyPhaseTrials
1Klonopin
EEngelhard Arzneimittel GmbH & Co.KG
Approved
Celexa
AbbViePreclinical
Inapsine
Alnylam PharmaceuticalsPreclinical
Ozempic
Novo NordiskPreclinical
Zocor
OOrganon and Co
Preclinical
Depakote
AbbViePreclinical
Ibrance
PfizerPreclinical
Comtan
Orion Corporation, Orion PharmaPreclinical
Persantine
Boehringer IngelheimPreclinical
Catapres
Boehringer IngelheimPreclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Burning Mouth Syndrome6 trials
Seizure3 trials
Fasting Conditions2 trials
REM sleep behavior disorder2 trials
14 more indications
Oral1 trial
Experimental1 trial
Withdrawal1 trial
Status Epilepticus1 trial
Central Sensitisation1 trial
Social Anxiety Disorder1 trial
Unspecified1 trial
Regulatory
FDA Approval Timeline[5]
Apr 9, 1997
KLONOPIN
NDA NDA017533
Dec 23, 1997
KLONOPIN RAPIDLY DISINTEGRATING
NDA NDA020813
Sources
References
- [1]
- [2]MedlinePlus Drug Information — Klonopin drug information. U.S. National Library of Medicine, National Institutes of Health.
- [3]
- [4]Open Targets Platform — Drug–disease associations for Clonazepam. EMBL-EBI & Wellcome Sanger Institute.
- [5]
- [6]
Details